Home » Topics » Disease categories and therapies » Hematologic

Hematologic
RSS

Prodrugs of thrombin inhibitors prepared at BMS

Nov. 18, 1997

Clinical safety and pharmacology of Vasoflux

Nov. 14, 1997

VM-201 preclinical data presented at AHA meeting

Nov. 14, 1997

Conformationally constrained arginal thrombin inhibitors prepared at Lusofarmaco/Guidotti

Nov. 13, 1997

Nonpeptide alphav/beta3 antagonist effective in rabbit model of neointima formation

Nov. 12, 1997

Potent and selective fibrinogen receptor antagonist presented by DuPont Merck

Nov. 12, 1997

C921-78: a new factor Xa antagonist prevents thrombosis with reduced blood loss

Nov. 12, 1997

Fibrinogen receptor occupancy, antiplatelet activity and safety of lefradafiban

Nov. 10, 1997

Lamifiban efficacy demonstrated in PARAGON trial

Nov. 10, 1997

Preclinical and clinical profile of Searle's fibrinogen antagonist

Nov. 10, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 10, 2026.
Cas and effect: Merck’s phase III ripples HIF-2α space
BioWorld
Oddsmakers wasted no time figuring the market chances after Merck & Co. Inc. rolled out data from the phase III Litespark-011 study testing its oral...
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...